MDCX logo

Medicus Pharma Ltd. Common Stock

MDCX
Healthcare|Biotechnology|CA
$1.87
+0.04 (+2.19%)
DCF Value
$4.14
Cash / Share
$4.56
Next Earnings Report
Mar 24, 2027
EPS est. -$6.50
Financing Filings (last 12 months)
48
Shelf registrations / offering prospectuses — latest Nov 6, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Medicus Pharma to Present at BIO-Europe 2026
Nov 5, 2026 · GlobeNewsWire
Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026
Nov 4, 2026 · GlobeNewsWire
Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing
Nov 4, 2026 · GlobeNewsWire
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
Oct 27, 2026 · GlobeNewsWire
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Oct 26, 2026 · GlobeNewsWire
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
Oct 8, 2026 · GlobeNewsWire
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
Sep 29, 2026 · GlobeNewsWire
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
Sep 21, 2026 · GlobeNewsWire
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
Sep 10, 2026 · GlobeNewsWire
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
Sep 8, 2026 · GlobeNewsWire

SEC Filings (222)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 2026425DocumentIndex
Nov 6, 2026424B3Offering prospectusDocumentIndex
Nov 6, 202610-QQuarterly reportDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Nov 4, 2026425DocumentIndex
Oct 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 26, 2026424B3Offering prospectusDocumentIndex
Oct 23, 20268-KMaterial eventDocumentIndex
Oct 19, 2026PRE 14AProxy / shareholder voteDocumentIndex
Oct 16, 2026424B3Offering prospectusDocumentIndex
Oct 16, 20268-KMaterial eventDocumentIndex
Oct 16, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 7, 2026424B3Offering prospectusDocumentIndex
Oct 7, 20268-KMaterial eventDocumentIndex
Sep 14, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Sep 14, 2026424B3Offering prospectusDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
Sep 11, 20268-KMaterial eventDocumentIndex
Sep 3, 2026424B3Offering prospectusDocumentIndex
Sep 3, 20268-KMaterial eventDocumentIndex
Aug 13, 2026424B3Offering prospectusDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Jun 4, 2026424B3Offering prospectusDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
May 28, 2026424B3Offering prospectusDocumentIndex
May 27, 20268-KMaterial eventDocumentIndex
May 14, 2026424B3Offering prospectusDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 4, 2026ARSAnnual report to holdersDocumentIndex
May 4, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 30, 2026424B3Offering prospectusDocumentIndex
Apr 29, 202610-K/AAnnual reportDocumentIndex
Apr 27, 2026424B3Offering prospectusDocumentIndex
Apr 24, 20268-KMaterial eventDocumentIndex
Apr 23, 2026424B3Offering prospectusDocumentIndex
Apr 21, 2026PRE 14AProxy / shareholder voteDocumentIndex
Mar 27, 2026EFFECTDocumentIndex
Mar 27, 2026EFFECTDocumentIndex
Mar 27, 2026EFFECTDocumentIndex